GENFIT
GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments. Their pioneering research is based on a strong heritage, stemming from in-house knowledge and their desire to strive for excellence. Their drug discovery efforts are based on selecting specific nuclear receptors as tar... gets and utilizing rational drug design to optimize their drug candidates. This strong skill base associated to their scientific and clinical expertise, translational disease-driven approach and strong bioinformatics capabilities, have allowed us to build a solid scientific platform enabling us to discover and develop their drug candidates and diagnostic tools. Professor Bart Staels, a world-renowned expert in nuclear receptors, co-founded GENFIT and has played a key role in shaping their company’s expertise over the years. Today, he sits as chair of the Scientific Advisory Board, lending decades of experience and essential know-how, supporting their role as an innovative leader in the discovery of solutions for the metabolic field.
GENFIT
Industry:
Biopharma Biotechnology Health Care
Founded:
1999-09-01
Address:
Loos, Nord-Pas-de-Calais, France
Country:
France
Website Url:
http://www.genfit.com
Total Employee:
101+
Status:
Active
Contact:
33320164001
Total Funding:
93.69 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Mereo Biopharma
Mereo is a new UK-based speciality biopharmaceutical company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Official Site Inspections
http://www.genfit.com Semrush global rank: 6.12 M Semrush visits lastest month: 1.32 K
- Host name: 107.154.238.20.ip.incapdns.net
- IP address: 107.154.238.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GENFIT"
About - Genfit
Listing of GENFIT on the Alternext Market of Euronext Paris and transferred in 2014 onto the Euronext Market in Paris (compartment B – ISIN: FR0004163111) ... 3 National organization for Rare Disorders, RDD FAQ 2019 4 Nguengang …See details»
Homepage - Genfit
Our Success in PBC. In June 2023, GENFIT and Ipsen announced positive topline 52-week data from the pivotal Phase 3 trial ELATIVE ® 2 evaluating elafibranor in Primary Biliary Cholangitis (PBC).This asset was discovered and …See details»
GENFIT - Crunchbase Company Profile & Funding
Professor Bart Staels, a world-renowned expert in nuclear receptors, co-founded GENFIT and has played a key role in shaping their company’s expertise over the years. Today, he sits as chair …See details»
Executive Commitee - GENFIT
Dean Hum is today a key person in the organization of GENFIT. In particular, he is responsible for defining, implementing, employing and coordinating short-, medium- and long-term strategies …See details»
GENFIT: Gearing Up for 2019 with Organizational Changes
Sep 24, 2018 Lille (France), Cambridge (Massachusetts, United States), September 24, 2018 – GENFIT (Euronext: GNFT – ISIN: FR0004163111) today announces some key leadership …See details»
GENFIT - Contacts, Employees, Board Members, Advisors
Organization. GENFIT . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 6. Number of Board …See details»
Homepage - Genfit
C’est le premier médicament développé en interne par GENFIT à obtenir l’approbation de la FDA américaine, une étape historique pour notre entreprise. Ipsen est désormais responsable des …See details»
GENFIT: Board of Directors, Represented by Chairman Jean …
Sep 2, 2019 Pascal joined GENFIT in May 2018 and has worked closely with Jean-François and Dean Hum, GENFIT’s COO and CSO, since his arrival. A key member of GENFIT’s Executive …See details»
Genfit Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Genfit has 5 employees across 2 locations and €28.57 m in annual revenue in FY 2023. See insights on Genfit including office locations, competitors, revenue, financials, …See details»
GENFIT career: recruitment in biopharmaceutical | GENFIT
GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential …See details»
Genfit CEO and Key Executive Team | Craft.co
Genfit's Chairman of the Board of Directors and Chief Executive Officer of GENFIT, Co-Founder is Jean-Francois Mouney. Other executives include Ph. D Dean Hum, Senior Executive VP …See details»
Genfit - Overview, News & Similar companies | ZoomInfo.com
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis Lille (France), Cambridge (Massachusetts, United States), Zurich …See details»
CSR Commitment - Genfit
At GENFIT, fostering innovation relies on creating an environment where employees can freely exchange ideas, engage in dialogue, and collaborate while upholding the scientific process. …See details»
GENFIT to Present Update on Scientific and Corporate Progress at …
Nov 2, 2023 GENFIT to lead 3 key events on ACLF during AASLD: ACLF Day for Investors/Analysts on November 11, 2023Patient Advocacy Council meeting on November 11, …See details»
GENFIT Reports First Half-Year 2022 Financial Results and Provides ...
In 2021, GENFIT signed an exclusive licensing agreement with IPSEN to develop, manufacture and commercialize elafibranor in PBC and other indications. 2 GENFIT is also developing …See details»
Therapeutic Areas - Genfit
GENFIT is a company that specializes in the discovery and development of drugs that target rare and life-threatening liver diseases with high unmet medical needs and is a world leader in …See details»
GENFIT: First Half-Year 2020 Financial Report and New Corporate ...
Dec 31, 2019 GENFIT | 885 Avenue Eugène Avinée, 59120 Loos - FRANCE | +333 2016 4000 | www.genfit.com 1 Note: the impact of the reclassification of foreign exchange income from …See details»
Genfit CARES - genfitllc.com
Genfit's mission is to deliver "A-Ha" moments to the industrial fittings industry. On April 8th, 2020, Genfit purchased the assets of O'Brien Brass. It was OBB's three generations of institutional …See details»
Expertise - Genfit
Liver Diseases. At GENFIT, we take pride in our longstanding expertise in the field of liver diseases. We have established ourselves as a leader in understanding and developing …See details»
GENFIT Reports First Half-Year 2021 Financial Results and Provides ...
GENFIT Reports First Half-Year 2021 Financial Results and Provides Corporate Update. Financial highlights . Cash and cash equivalents totaled €104 million as of June 30, 2021 …See details»